中国创伤骨科患者围手术期静脉血栓栓塞症预防指南(2021)

2021-03-25 中华医学会骨科学分会 中华创伤骨科杂志.2021.23(3):185-192.

静脉血栓栓塞症(venous thromboembolism,VTE)是创伤骨科患者的常见并发症,也是导致患者围手术期死亡的主要原因之一。对创伤患者施以有效的预防措施,可以降低VTE的发生风险,减轻患

中文标题:

中国创伤骨科患者围手术期静脉血栓栓塞症预防指南(2021)

发布日期:

2021-03-25

简要介绍:

静脉血栓栓塞症(venous thromboembolism,VTE)是创伤骨科患者的常见并发症,也是导致患者围手术期死亡的主要原因之一。对创伤患者施以有效的预防措施,可以降低VTE的发生风险,减轻患者痛苦,减少医疗费用。因此,参照2016版“中国骨科大手术静脉血栓栓塞症预防指南”、2018版“中国血栓性疾病防治指南”及最新的循证证据,在2012版“中国骨科创伤患者围手术期静脉血栓栓塞症预防的专家共识”基础上,制定本指南。根据创伤患者独特的临床特点,着眼于创伤患者VTE的预防,从而进一步规范预防方法和提高预防水平。本指南仅为学术性指导意见,具体使用时必须依据患者的具体医疗情况而定。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (31)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1197674, encodeId=d03d119e6746b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Feb 27 09:17:53 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195738, encodeId=fea41195e38e2, content=正是我想要的最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Mon Feb 21 16:45:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192094, encodeId=c98711920942d, content=好好👍,非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb25689158, createdName=ms1000000696242905, createdTime=Thu Feb 10 23:02:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191284, encodeId=f33d1191284b9, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Wed Feb 09 00:20:17 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187531, encodeId=9b4e118e5312f, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454c2499440, createdName=124963d4m60暂无昵称, createdTime=Sun Jan 23 20:40:32 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-02-27 huihui0728

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1197674, encodeId=d03d119e6746b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Feb 27 09:17:53 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195738, encodeId=fea41195e38e2, content=正是我想要的最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Mon Feb 21 16:45:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192094, encodeId=c98711920942d, content=好好👍,非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb25689158, createdName=ms1000000696242905, createdTime=Thu Feb 10 23:02:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191284, encodeId=f33d1191284b9, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Wed Feb 09 00:20:17 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187531, encodeId=9b4e118e5312f, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454c2499440, createdName=124963d4m60暂无昵称, createdTime=Sun Jan 23 20:40:32 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-02-21 109034249

    正是我想要的最新指南

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1197674, encodeId=d03d119e6746b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Feb 27 09:17:53 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195738, encodeId=fea41195e38e2, content=正是我想要的最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Mon Feb 21 16:45:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192094, encodeId=c98711920942d, content=好好👍,非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb25689158, createdName=ms1000000696242905, createdTime=Thu Feb 10 23:02:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191284, encodeId=f33d1191284b9, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Wed Feb 09 00:20:17 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187531, encodeId=9b4e118e5312f, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454c2499440, createdName=124963d4m60暂无昵称, createdTime=Sun Jan 23 20:40:32 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-02-10 ms1000000696242905

    好好👍,非常棒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1197674, encodeId=d03d119e6746b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Feb 27 09:17:53 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195738, encodeId=fea41195e38e2, content=正是我想要的最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Mon Feb 21 16:45:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192094, encodeId=c98711920942d, content=好好👍,非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb25689158, createdName=ms1000000696242905, createdTime=Thu Feb 10 23:02:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191284, encodeId=f33d1191284b9, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Wed Feb 09 00:20:17 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187531, encodeId=9b4e118e5312f, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454c2499440, createdName=124963d4m60暂无昵称, createdTime=Sun Jan 23 20:40:32 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-02-09 1501e8a265m

    下载学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1197674, encodeId=d03d119e6746b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Feb 27 09:17:53 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195738, encodeId=fea41195e38e2, content=正是我想要的最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Mon Feb 21 16:45:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192094, encodeId=c98711920942d, content=好好👍,非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb25689158, createdName=ms1000000696242905, createdTime=Thu Feb 10 23:02:03 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191284, encodeId=f33d1191284b9, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Wed Feb 09 00:20:17 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187531, encodeId=9b4e118e5312f, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454c2499440, createdName=124963d4m60暂无昵称, createdTime=Sun Jan 23 20:40:32 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-01-23 124963d4m60暂无昵称

    很有用

    0

拓展阅读

2014 ASCO 癌症患者静脉血栓栓塞防治指南(更新版)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-01-20

2015 ACFAS临床共识声明:需要进行固定的足踝部手术以及外伤静脉血栓血栓栓塞疾病的危险因素,预防和诊断

美国足踝外科医师协会(ACFAS,American College of Foot and Ankle Surgeons) · 2015-03-19

NCS:2015 预防神经重症监护患者静脉血栓指南

美国神经重症监护学会(NCS,Neurocritical Care Society) · 2015-05-14

2015 BCSH指南:肿瘤相关静脉血栓形成

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2015-06-26

2016 妊娠相关静脉血栓栓塞症的诊断共识

国外妇产科相关专家组 · 2016-08-10